News Analysis

by Jody Ranck | March 30, 2020

Global Responses to COVID-19

Pandemics are by definition a global issue and it is in the interest of all nations to pay attention to the global response to the emerging COVID-19 outbreak. This is not a time for myopic views or “America First” at the exclusion of learning lessons in real-time from what is

by John Moore | March 25, 2020

COVID-19: Free Health IT Resources

I founded Chilmark Research to help move the healthcare industry forward to improving care delivery through the effective use of information technology (IT). A key part of that mission is to educate by providing all stakeholders with objective research and resources. Today, the world is seeing a nearly unprecedented spread

by John Moore |

Does a PHM Strategy Give Leg-up During COVID19?

As the #COVID19 pandemic storms across the U.S., a thought I’ve been pondering is: Will there be a measurable difference in ability to respond by those healthcare systems that have aggressively moved forward with adopting a population health management (PHM) strategy and supporting technology coupled with value-based care (VBC) models?

by John Moore | March 20, 2020

The Approaching #COVID19 Tsunami – Our Response

Several weeks ago we were preparing for HIMSS’20 – something the entire Chilmark Research team attends every year. HIMSS'20 was cancelled. Today, we are completely virtual. Luckily, this is not a drastic leap for us as I started Chilmark Research 13 years ago with a virtual model in mind, using

by Brian Murphy | March 16, 2020

Take a Break From Worrying About COVID-19. We Have New Rules!

New rules from CMS and ONC hold few surprises for devotees of the regulatory process – a niche crowd, admittedly. Both agencies thoroughly communicated and responded to the industry at every step. What’s more, the functional aspects in these requirements are already being done — somewhere in the U.S. healthcare system.

by Brian Murphy | February 07, 2020

Will the New Interoperability Rules Tame or Be Tamed by Fees?

The healthcare exchange status quo got a boost last week in a legal victory for Ciox Health. The release of information vendor challenged HHS guidance that limited the fees it could charge when patients asked it to transmit their data to third parties. The decision frees companies from constraints on

by John Moore | February 05, 2020

Epic Wrong Turn

Or Interop, Privacy and Advancing Care The annual ONC meeting last week brought together stakeholders to discuss policy for health IT and most importantly, interoperability. With new interoperability rules expected in the coming weeks, this was a particularly important meeting with no less than HHS Sec. Azar giving a keynote.

by Alex Lennox-Miller | January 30, 2020

Guidance on Clinical Decision Support: Definitions and Transparency

Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. The FDA was criticized for not basing their first draft regulation criteria on use-case risk. Since then the International Medical Device Regulators Forum (IMDRF), which the FDA chaired, created a
View More >>

Stay up to the minute.

[bestwebsoft_contact_form]